Gottlieb: No ‘Plan B’ If Woodcock Isn’t Nominated As US FDA Commissioner

Janet Woodcock would continue tackling issues including bogus COVID-19 claims and heavy metals in baby food if nominated as FDA commissioner, says former head Scott Gottlieb. He praises Woodcock’s “great judgment” and her view on policy that will “expand across the agency.”

WHITE OAK, MD - JULY 20: A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland. (Photo by Sarah Silbiger/Getty Images)
(Sarah Silbiger/Getty Images)

Former commissioner Scott Gottlieb doesn’t see a “plan B” for US Food and Drug Administration leadership beyond Janet Woodcock being moved from acting to permanent commissioner.

Gottlieb also expects that enforcing against bogus COVID-19 treatment claims and keeping heavy metals out of baby food will remain...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Leadership

More from HBW Insight